Celiprolol: novel activity at adrenoceptors may improve tolerability

Yedinak KC. PharmacoEconomics 4: 104–121, 1993 Kendall MJ, Rajman I. Drug Saf 10: 220–232, 1994 Milne RJ, Buckley MMT. Drugs 41: 941–969, 1991 British National Formulary 27: 67–74, 1994 Dujovne CA, et al. Am J Cardiol 72: 1131–1136, 1993 Fogari R, et al. Curr Ther Res 47: 879–888, 1990 Riddell JG, et al. Drugs 34: 438–458, 1987 McInnes GT, et al. Am Heart J 116: 1437–1438, 1988 Vyssoulis GP, et al. Cardiovasc Drugs Ther 6: 419–424, 1992 Kjekshus JK. Am J Cardiol 57: 43F–49F, 1986 McLenachan JM, Dargie HJ. Am Heart J 121: 688–690, 1991 Lamon KD. Am Heart J 121: 683–687, 1991 Hoffmann W, Hoffmann H. J Cardiovasc Pharmacol 8 (Suppl. 4): 88–90, 1986 Herrmann JM, et al. Eur Heart J 9 (Suppl. 1): 114, 1988 Drugs Ther Perspect 2: 1–4, 2 Aug 1993